about
New Commercially Available IgG Kits and Time-Resolved Fluorometric IgE Assay for Diagnosis of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis.Azole-resistant Aspergillus fumigatus isolate with the TR34/L98H mutation in both a fungicide-sprayed field and the lung of a hematopoietic stem cell transplant recipient with invasive aspergillosis.Assessment of pets (cats and dogs) in homes using electrostatic dust collectors and QPCR: new tools to evaluate exposure and risk of allergies.Microbiological characterization of 3193 French dwellings of Elfe cohort children.Azole-resistant Aspergillus fumigatus in sawmills of Eastern France.Quantification of Saprolegnia parasitica in river water using real-time quantitative PCR: from massive fish mortality to tap drinking water.Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).[Azole resistance with environmental origin: What alternatives for the future?].Simultaneous removal of five triazole fungicides from synthetic solutions on activated carbons and cyclodextrin-based adsorbentsQuantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.DNA metabarcoding to assess indoor fungal communities: Electrostatic dust collectors and Illumina sequencing.Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.qPCR detection of Lichtheimia species in bandages associated with cutaneous mucormycosis in burn patients.Sinus aspergillosis due to an azole-resistant Aspergillus fumigatus strain carrying the TR34/L98H mutation in immunocompetent host.Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis.Wheezing phenotypes and risk factors in early life: The ELFE cohort.Correction: Wheezing phenotypes and risk factors in early life: The ELFE cohort.Evaluation of mold exposure in cystic fibrosis patients' dwellings and allergic bronchopulmonary risk[Fungal and bacterial contamination of 30 general practitioners' consultation room in Franche-Comté (eastern France)]Replies to "Is the home environment an important factor in the occurrence of fungal events in cystic fibrosis?"qPCR standard operating procedure for measuring microorganisms in dust from dwellings in large cohort studies[European birth cohorts: Early life exposure to microorganisms and health impact]Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary MucormycosisIndoor Microbiome: Quantification of Exposure and Association with Geographical Location, Meteorological Factors, and Land Use in FranceAzole-resistant Aspergillus fumigatus in the hospital: Surveillance from flower beds to corridorsDetermination of azole fungal residues in soils and detection of Aspergillus fumigatus-resistant strains in market gardens of Eastern FranceHypersensitivity pneumonitis: A new strategy for serodiagnosis and environmental surveysIdentifying indoor air Penicillium species: a challenge for allergic patients
P50
Q36665650-26E41FCA-A413-462B-8AE1-E0BDF4B5FD83Q37713702-8F5C13EB-E12A-46AF-A569-EA81C5313195Q38828192-AABFD19E-5F1C-4A9C-8691-056745078DD4Q39086673-EDBCC124-4CC0-431C-B524-8CF230CB651EQ40215709-CBDB1109-F6F5-4310-9D5E-86529703B659Q40502716-126737E8-81C1-48AF-A484-45459997FD36Q40856576-7EA88B6A-3224-4EAC-A95F-59540F4BC58EQ41077342-D1E1AF50-346F-41A4-9A15-5EDE56C25DF6Q41563305-DEA4F203-9148-4A6A-BC9E-98C6FE6466B2Q44801909-53F6155D-03F2-4956-82A0-7D4146AC1C29Q46358905-29F10CDA-C040-49FC-A9C5-78225F7E7568Q46920426-77B5A5F4-96E5-4D91-B006-FE77A4810FADQ50060593-BA32C3AD-5260-4092-B8ED-E5D9FE8EE337Q51697464-1F40ECBA-650E-406A-B1D3-E5730766F49BQ54224348-9313B331-9E09-42E5-A2CD-C4B2096ACA59Q55307497-288D5201-EAF4-4C26-9220-C29895F79DD4Q64974419-D055D4B7-2FC6-4E7A-8307-F13AD89E87BEQ86581337-2CA02501-1BDB-47CB-9A2C-3A3B42053C4EQ87098065-A1A3AC11-6ABE-4FD3-B051-0CE0E49BB8FBQ87098942-F95A79D2-318D-4CC0-ABA1-A4C5199E9F4AQ87304797-EBAE791E-5814-4D8B-BFBE-32306272435CQ88476011-7FDD856E-FBD1-414E-96FA-87A51E43D1F5Q89013302-4095CEFF-0678-42B1-BDA5-A6EE2D179101Q89976839-88BC6CF2-A651-427D-8087-A2C01CC8DFF8Q91383609-2D9E0B27-1226-4BC4-A2CE-B8CC759B730BQ91442559-45B707B6-09AE-4A9E-8C37-C21E32787919Q92950854-0C71DBA9-B731-4787-88BD-B92E102AA653Q93124811-1CA0F071-9AF4-4440-A17B-7930BE5ABAEA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Steffi Rocchi
@ast
Steffi Rocchi
@en
Steffi Rocchi
@es
Steffi Rocchi
@nl
type
label
Steffi Rocchi
@ast
Steffi Rocchi
@en
Steffi Rocchi
@es
Steffi Rocchi
@nl
prefLabel
Steffi Rocchi
@ast
Steffi Rocchi
@en
Steffi Rocchi
@es
Steffi Rocchi
@nl
P106
P1153
55682439800
P31
P496
0000-0001-9262-1127